Showing results (11-20 of 170) with videos related to
Sort By:
Pageof 17
Medical Care|October 25, 2007
Use of propensity score technique to account for exposure-related covariates: an example and lessonJohn D Seeger, Tobias Kurth, Alexander M WalkerThe American Journal of Medicine|October 5, 2001
Clinically relevant differences between the statins: implications for therapeutic selectionP H Chong, J D Seeger, C FranklinAnnals of Epidemiology|February 6, 2016
Implications of immortal person-time when outcomes are nonfatalCaihua Liang, John D Seeger, David D DoreHospital Pharmacy|December 1, 1995
Control charts to monitor rates of adverse drug reactionsG T Schumock, J D Seeger, S X KongPharmacotherapy|December 17, 1998
Characteristics associated with ability to prevent adverse drug reactions in hospitalized patientsJ D Seeger, S X Kong, G T SchumockTherapeutic Advances in Drug Safety|August 2, 2014
Incidence of health insurance claims for thyroid neoplasm and pancreatic malignancy in association with exenatide: signal refinement using active safety surveillanceDavid D Dore, John D Seeger, K Arnold ChanAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 15, 1996
Estimating the rate of adverse drug reactions with capture-recapture analysisJ D Seeger, G T Schumock, S X KongArthritis and Rheumatism|October 19, 2000
A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritisH K Choi, J D Seeger, K M KuntzThe Journal of Rheumatology|June 18, 2002
A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritisHyon K Choi, John D Seeger, Karen M KuntzPharmacoepidemiology and Drug Safety|February 1, 2012
Vaccine discontinuation and switching following regulatory interventions in response to rotavirus vaccine contamination with porcine circovirus DNA fragmentsDavid D Dore, Bruce R Turnbull, John D SeegerPageof 17